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The human N-acetyltransferase genes NAT1 and NAT2 encode two phase-II enzymes that metabolize various drugs
and carcinogens. Functional variability at these genes has been associated with adverse drug reactions and cancer
susceptibility. Mutations in NAT2 leading to the so-called slow-acetylation phenotype reach high frequencies world-
wide, which questions the significance of altered acetylation in human adaptation. To investigate the role of
population history and natural selection in shaping NATs variation, we characterized genetic diversity through the
resequencing and genotyping of NAT1, NAT2, and the pseudogene NATP in a collection of 13 different populations
with distinct ethnic backgrounds and demographic pasts. This combined study design allowed us to define a detailed
map of linkage disequilibrium of the NATs region as well as to perform a number of sequence-based neutrality
tests and the long-range haplotype (LRH) test. Our data revealed distinctive patterns of variability for the two
genes: the reduced diversity observed at NAT1 is consistent with the action of purifying selection, whereas NAT2
functional variation contributes to high levels of diversity. In addition, the LRH test identified a particular NAT2
haplotype (NAT2*5B) under recent positive selection in western/central Eurasians. This haplotype harbors the
mutation 341TrC and encodes the “slowest-acetylator” NAT2 enzyme, suggesting a general selective advantage
for the slow-acetylator phenotype. Interestingly, the NAT2*5B haplotype, which seems to have conferred a selective
advantage during the past ∼6,500 years, exhibits today the strongest association with susceptibility to bladder
cancer and adverse drug reactions. On the whole, the patterns observed for NAT2 well illustrate how geographically
and temporally fluctuating xenobiotic environments may have influenced not only our genome variability but also
our present-day susceptibility to disease.
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The two human N-acetyltransferase genes, NAT1 (MIM
108345) and NAT2 (MIM 243400), represent one of
the first and clearest examples of the importance of ge-
netic variation among individuals and across popula-
tions in drug response (Weber 1987). The two homolo-
gous genes are situated within a 200-kb region in 8p22,
together with the NATP pseudogene (fig. 1). Both genes
encode phase-II enzymes named “arylamine N-acetyl-
transferases” (NATs), which catalyze the transfer of an
acetyl group to different arylhydrazines and arylamine
drugs (Blum et al. 1990). Both genes carry functional
polymorphisms whose effects on enzymatic activity have
been well studied (Hein et al. 2000). Whereas the var-
iants associated with reduced activity attain only low
frequencies in NAT1, they constitute common poly-
morphisms in NAT2 (Upton et al. 2001). Two main
classes of NAT2 phenotypes are therefore observed: the
“fast-acetylation” phenotype, which refers to the wild-
type acetylation activity, and the “slow-acetylation”
phenotype, which results in reduced protein activity. In
addition, NAT1 and NAT2 metabolize numerous com-
mon carcinogens, and variation in these genes can result
in varying susceptibility to cancer (for a review, see the
work of Hein [2002]). For example, the slow-acetylator
NAT2 phenotype has been associated with side effects
to the commonly used antitubercular isoniazid (Huang
et al. 2002) and with higher risk for bladder cancer
(Cartwright et al. 1982; Garcia-Closas et al. 2005). Nev-
ertheless, most NAT2 mutations leading to the slow phe-
notype are found at high frequencies worldwide, calling
into question the role of altered acetylation in human
adaptation. Moreover, the function of NATs in medi-
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Figure 1 Schematic representation of the NATs region spanning
1200 kb. Sequenced loci are represented by boxes (black boxes p
coding regions; gray boxes p flanking regions; white boxes p inter-
genic regions), and arrows indicate the positions of genotyped SNPs.
ating the interactions between humans and their xeno-
biotic environment, which varies depending on diet and
lifestyle, makes them excellent targets for the action of
natural selection. Indeed, several studies have identified
the signature of different selective pressures in genes in-
volved in the metabolism of exogenous substances, in-
cluding the members of the CYP3A family (Thompson
et al. 2004), CYP1A2 (Wooding et al. 2002), LCT (Ber-
saglieri et al. 2004), TAS2R16 (Soranzo et al. 2005),
PTC (Wooding et al. 2004), HFE (Toomajian and Kreit-
man 2002; Toomajian et al. 2003), MDR1 (Tang et al.
2004), and MRP1 (Wang et al. 2005).
The main objective of the present study was to in-
vestigate the evolutionary history of the NATs region by
unraveling the relative influences of natural selection and
human demography in determining its present-day var-
iability. With this goal in mind, we first resequenced
NAT1, NAT2, and the pseudogene NATP in a multi-
ethnic panel of 80 individuals (referred to as the “re-
sequencing panel”). To further investigate the global
linkage disequilibrium (LD) patterns in the NATs region,
we selected 21 SNPs—including 5 NAT1 and 7 NAT2
SNPs retrieved from the initial sequence-based data set
as well as 9 intergenic SNPs—to cover the entire 200-
kb region (fig. 1). These markers were all genotyped in
an extended collection of 563 individuals (referred to as
the “genotyping panel”) originating from 13 different
ethnologically well-defined human populations. Coales-
cent methods, sequence-based neutrality tests, and the
long-range haplotype (LRH) test (Sabeti et al. 2002)
were performed to provide insight into the role of these
genes in human adaptation to geographically and his-
torically fluctuating xenobiotic environments.
Subjects and Methods
DNA Samples
The resequencing panel consisted of 80 individuals (160
chromosomes) from eight populations representing major geo-
graphic regions; sub-Saharan African chromosomes were rep-
resented by Bakola Pygmies from Cameroon (20) and by Bantu
speakers from Gabon (20); western Eurasian samples were
represented by Ashkenazi Jews (20), Sardinians (12), French
(20), and Saami from Finland (20); and eastern Eurasian sam-
ples were represented by Indians from Gujarat (20) and by
Thai (28). One chimpanzee (Pan troglodytes) was also se-
quenced to define the ancestral state of each mutation. The
genotyping panel consisted of 563 individuals (1,126 chro-
mosomes) from 13 populations. Sub-Saharan African chro-
mosomes were represented by Bakola Pygmies (80) and Baka
Pygmies (60) from Cameroon, Ateke Bantu speakers from Ga-
bon (100), and Somali (48); North African and western and
central Eurasian samples were represented by Morrocans (88),
Ashkenazi Jews (80), Sardinians (98), Swedes (100), Saami
from Finland (96), and Turkmen from Uzbekistan (100); and
eastern Eurasian samples were represented by Gujarati from
India (100), Chinese from the Hunan and Zhejang regions
(88), and Thai (88). All individuals were healthy donors from
whom informed consent was obtained.
PCR and Sequence Determination
Six different regions were PCR amplified, for a total of ∼8.5
kb per chromosome (fig. 1): the entire coding exon of the
NAT1 gene (870 bp) and 1,735 bp of noncoding flanking parts
(1,122 bp in 5′ end and 613 bp in 3′ end); the entire coding
exon of the NAT2 gene (870 bp) and 1,950 bp of noncoding
flanking parts, including 1,603 bp surrounding its first non-
coding exon; the pseudogene NATP (2,145 bp); and two in-
tergenic noncoding regions at 10 kb and 100 kb (1,068 bp)
from NAT1 5′ end. Details about PCR and sequencing con-
ditions are available on request. As a measure of quality con-
trol for the data, individuals presenting singletons or ambig-
uous polymorphisms were reamplified and resequenced. Se-
quences were analyzed using the GENALYS software (Taka-
hashi et al. 2003).
Selection and Genotyping of Polymorphisms
The newly discovered sequence-based variation was used to
determine the minimal number of SNPs able to distinguish the
haplotypic diversity (haplotype-tagging SNPs [htSNPs]) of
NAT1 and NAT2 loci in a given population. Five SNPs and
one (TAA)n microsatellite were typed in NAT1 by either ge-
notyping or sequencing, and seven SNPs were genotyped in
the NAT2 coding region. In addition, we genotyped nine in-
tergenic SNPs selected because they were polymorphic in all
human populations (fig. 1). These SNPs were chosen either
from dbSNP (when dbSNPs met the previous criterion) or from
the intergenic regions sequenced here. Genotyping was per-
formed by either fluorescence polarization (VICTOR-2TM
technology) or TaqMan (ABI Prism-7000 Sequence Detection
System) assays.
Sequence-Based Data Analysis
Allele frequencies were determined by gene counting, and
deviations from Hardy-Weinberg equilibrium were tested by
Arlequin v.2.001 (Schneider et al. 2000). Haplotype recon-
struction was performed using the Bayesian method imple-
mented in PHASE v.2.1.1 (Stephens and Donnelly 2003), and
htSNPs were defined using BEST v.1.0 (Sebastiani et al. 2003),
after the exclusion of singletons because they could not be
positioned with certainty on a given haplotypic context. With
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Table 1
Polymorphisms Identified through the Resequencing
Survey of the NATs Region
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
the use of phased data, the neutral parameter vML and the time
since the most recent common ancestor (TMRCA) were estimated
by maximum likelihood with GENETREE (Griffiths and Ta-
vare´ 1994), under a standard coalescent model. Since this
model assumes no recombination, for this particular analysis
we had to exclude a few SNPs or rare recombinant haplotypes
(in NAT1, the first four 5′ SNPs; in NATP, three singleton
haplotypes; in NAT2, two singleton haplotypes). Time, scaled
in 2Ne units, was converted into years by use of a 25-year
generation time and an Ne value obtained as vML divided by
4m. The mutation rate per gene per generation (m) was deduced
from Dxy, the average number of nucleotide substitutions per
site between human and chimpanzee (Nei 1987, equation
10.20), calculated by DnaSP v.4.0 (Rozas et al. 2003), with
consideration that the two species diverged 200,000 genera-
tions ago. Simulations were performed to estimate the prob-
ability of a TMRCA greater than a given value, under a Wright-
Fisher model. Fifty thousand simulations were performed using
a version of the MS program modified to obtain TMRCA values
(R. Hudson, personal communication).
Using DnaSP, we calculated the nucleotide diversity (p) and
Watterson’s estimator of v (vW) (Watterson 1975), and we per-
formed a number of statistical tests: Tajima’s D (TD) (Tajima
1989), Fu and Li’s F* (Fu and Li 1993), Fay and Wu’s H (Fay
and Wu 2000), KA/KS (Kimura 1968), the Hudson-Kreitman-
Aguade´ (HKA) test (Hudson et al. 1987), and the McDonald-
Kreitman (MK) test (McDonald and Kreitman 1991). A neu-
trality test based on the expected heterozygosity was also
performed with the Bottleneck program (Cornuet and Luikart
1996) on the NAT1 3′ UTR microsatellite, by the use of co-
alescent simulations (10,000 runs) and with the assumption
of different mutational models (stepwise mutation model and
two-phased mutation model with 0%–40% of multistep
changes).
Genotyping-Based Data Analysis
Pairwise LD between the 21 genotyped SNPs was estimated
after the exclusion, in each population, of SNPs with a minor-
allele frequency (MAF) !0.10. Using DnaSP, we calculated the
statistics D′ (Lewontin 1964) and r2 (Hill and Robertson 1968)
and tested their statistical significance, using a Fisher’s exact
test followed by Bonferroni corrections. To perform the LRH
test, we selected two core regions (in NAT1, SNPs 445, 1088,
1095, and 1191; in NAT2, SNPs 341, 481, 590, 803, and 857)
identified as haplotype blocks, following the criteria of Gabriel
et al. (2002), and we assessed, for each core haplotype, its
relative extended haplotype homozygozity (REHH) 200 kb
apart. To test the significance of potentially selected core hap-
lotypes, we first compared our sub-Saharan African and non-
African data sets with coalescent simulations of 1-Mb regions,
assuming a neutral model of evolution with recombination
(Hudson 2002). Model parameters (including demography
and recombination rate) were consistent with current estimates
for African and non-African populations (Schaffner et al.
2005). Similarly, our sub-Saharan African and non-African
data sets were compared with the empirical distribution of
“core haplotype frequencies versus REHH” obtained from the
screening of the entire chromosome 8 in Yoruban and Euro-
pean-descent populations, respectively (HapMap database).
To infer the population growth rate, r, and the age, g, of
NAT2 nonsynonymous mutations, we used a joint maximum-
likelihood estimation of these parameters, as described in Aus-
terlitz et al. (2003). We compared these results with coalescent-
based estimations of the two parameters: the growth rate
estimation of Slatkin and Bertorelle (2001) and the Reeve and
Rannala (2002) age estimation using the DMLE v.2.2 soft-
ware. One million iterations were performed for each esti-
mation. The recombination parameter required for these anal-
yses was estimated by comparing deCODE and Marshfield
genetic and physical distances in the NATs region (UCSC Ge-
nome Bioinformatics). The coefficient of selection, s, of the
NAT2 mutation 341TrC was estimated using the determin-
istic equation 3.29 of Wright (1969), which relates the fre-
quency of an allele in generation to its frequency in gen-t 1
eration t. We stated the degree of dominance, h, to 0.0
(recessivity) and 0.5 (codominance). We assumed the fre-
quency, p0, of the C allele before selection to vary between
0.05 and 0.15 (corresponding to the allele frequency in Pyg-
mies and eastern Eurasians). Making these assumptions, we
calculated the s values that would yield a frequency of 0.50
(the present-day frequency of the 341C allele in western Eu-
rasians) from its initial p0 frequency in g generations.
Results
NATs Nucleotide Sequence Variation
The initial sequencing screening of the resequencing
panel yielded a total of 111 mutations, including 68
transitions, 34 transversions, 8 insertions/deletions, and
1 triallelic microsatellite (table 1) (GenBank accession
numbers DQ305496–DQ305975). In NAT1, we ob-
served 2 nonsynonymous and 4 synonymous SNPs in its
coding region and 26 SNPs and the triallelic (TAA)n
microsatellite in its flanking regions. In the NAT2 coding
region, we found two synonymous and eight nonsynon-
ymous mutations, three of which were newly identified
(L24I, T193M, and Y208H). These three variants were
singletons and were restricted to sub-Saharan samples.
In addition, 14 SNPs and 3 indels in NAT2 flanking
regions were observed. In NATP, we identified 32 SNPs
and 5 indels. For all the SNPs, only 1.54% of the tests
departed significantly from Hardy-Weinberg equilib-
rium. However, these few tests would become nonsig-
nificant after a correction for multiple testing.
The nucleotide diversity, p, in the NAT1 and NAT2
coding and flanking regions as well as in the pseudogene
NATP is reported in table 2. Interestingly, the two du-
plicated NAT genes, which share 87.3% of nucleotide
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Table 2
Diversity Indices of NAT1, NAT2, and NATP Sequences
POPULATION
NAT1 CODING
REGION
(870 bp)
NAT1 CODING
AND FLANKING
REGIONS
(2,605 bp)
NAT2 CODING
REGION
(870 bp)
NAT2 CODING
AND FLANKING
REGIONS
(2,820 bp)
NATP PSEUDOGENE
(2,145 bp)
vW
(%)
p
(%) HD
vW
(%)
p
(%) HD
vW
(%)
p
(%) HD
vW
(%)
p
(%) HD
vW
(%)
p
(%) HD
Bakola .065 .023 .100 .108 .118 .821 .194 .195 .768 .110 .113 .863 .263 .223 .863
Bantu .000 .000 .000 .087 .101 .811 .259 .283 .789 .140 .136 .837 .368 .247 .884
Ashkenazi .000 .000 .000 .043 .043 .353 .162 .295 .611 .130 .143 .742 .092 .107 .821
Sardinian .000 .000 .000 .076 .091 .667 .190 .277 .621 .141 .135 .636 .093 .085 .758
French .097 .034 .100 .238 .126 .516 .162 .270 .721 .130 .136 .789 .079 .079 .653
Saami .000 .000 .000 .043 .065 .563 .194 .278 .747 .140 .179 .853 .092 .100 .789
Gujarati .097 .034 .100 .227 .110 .432 .194 .277 .732 .130 .171 .837 .079 .089 .837
Thai .012 .056 .204 .227 .170 .733 .177 .227 .728 .146 .164 .812 .084 .106 .870
Total .012 .021 .073 .217 .112 .662 .203 .275 .767 .151 .157 .841 .297 .134 .855
NOTE.—HD p haplotype diversity.
Table 3
Allelic Composition and Frequency of NAT1
Haplotypes in Our Resequencing Panel
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
identity in their coding region, showed completely dif-
ferent diversity levels, with the NAT2 coding region
( ) being 13 times more diverse than thepp 0.275%
NAT1 coding region ( ). To evaluate wheth-pp 0.021%
er these differences were due to the local variation in
substitution rates, we estimated the mutation rates per
generation per nucleotide of NAT1 and NAT2 coding
regions as well as that of NATP, which equaled 3.73#
108, 3.96 # 108, and 5.94 # 108, respectively.
Haplotype Diversity and TMRCA Estimates of NAT Loci
Haplotypes of the NAT genes were reconstructed first
by use of the sequence data obtained from the resequ-
encing panel (tables 3 and 4). The most unusual obser-
vation was the haplotype diversity of the NAT1 locus,
made of two highly divergent haplotype clusters sepa-
rated by 17 mutations. One cluster contained most of
NAT1 haplotype diversity (97.5%), whereas the other
contained a unique haplotype, called “NAT1*11A,”
that was observed in just three non-African individuals
(one heterozygous French, one heterozygous Gujarati,
and one homozygous Thai). Consequently, diversity es-
timates of the NAT1 locus were inflated in these three
populations, as attested by the much higher vW values
in the French, Gujarati, and Thai samples, as compared
with all other populations (table 2).
As for the genotyping panel, NAT1 and NAT2 hap-
lotype frequencies are reported in tables 5 and 6. Two
NAT1 haplotypes, NAT1*10 and NAT1*4, account for
85%–100% of NAT1 diversity. In addition, genotyping
results confirmed the sequence data, in that the diver-
gent and low-frequency NAT1*11A haplotype is re-
stricted to Eurasian populations. As for NAT2, the an-
cestral haplotype NAT2*4 and the remaining haplotypes
associated with the fast-acetylator phenotype (NAT2*12
and NAT2*13) were most frequent in Bakola Pygmies
and eastern Eurasians. Among the derived haplotypes
associated with the slow-acetylator phenotype, NAT2*14
(191GrA) was African specific, NAT2*7 (857GrA)
was observed mainly in eastern Eurasians, NAT2*5
(341TrC) was common in western and central Eura-
sians as well as in sub-Saharan Africans (Pygmies ex-
cepted), and NAT2*6 (590GrA) was found ubiqui-
tously at intermediate frequencies.
To investigate the tree topology and time depth of the
three NAT loci, we next estimated the gene tree and the
TMRCA of NAT1, NAT2, and NATP. The two divergent
NAT1 lineages coalesced 2.01 0.29 million years ago
(MYA) (fig. 2), one of the highest estimated TMRCA values
in the human genome (Excoffier 2002). By contrast, the
TMRCA values of NAT2 (1.01  0.27 MYA) and NATP
(1.05  0.24 MYA) were in agreement with neutral
expectations, since most human neutral loci should co-
alesce ∼4Ne generations ago (i.e., ∼1 MYA) (Takahata
1993).
Population Variation in LD Patterns
To determine global LD patterns in the 13 populations
of our genotyping panel, we estimated D′ and r2 for the
NATs region (data not shown). Both NAT1 and NAT2
genes showed significant and strong intragenic LD levels:
the proportion of SNP pairs in significant LD equaled
87.5% and 89.6% in Africans and non-Africans, re-
spectively, at the NAT1 locus and 73.7% and 84.0% at
NAT2. The genomic structure of the entire 200-kb NATs
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Table 4
Allelic Composition and Frequency of NAT2
Haplotypes in Our Resequencing Panel
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Table 5
Allelic Composition and Frequency of NAT1
Haplotypes in Our Genotyping Panel
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
region was made of two independent haplotype blocks,
one corresponding to NAT1 and the other to NATP and
NAT2. Further, we observed strong population variation
in LD levels when plotting the proportion of SNP pairs
in significant LD against physical distance for each pop-
ulation separately (fig. 3). Sub-Saharan Africans showed
lower LD levels than non-Africans, with the clear ex-
ception of Bakola Pygmies. Both western and eastern
Eurasians exhibited similar LD patterns, excluding the
Saami, who were, by far, the population with the highest
degree of allelic association.
Tests of the Standard Neutral Model
The absence of LD between the two NAT genes in all
populations enabled us to study the evolutionary forces
independently shaping NAT1 and NAT2 diversity. For
the NAT1 coding region, tests were not feasible in four
of eight populations because of a complete absence of
exonic variation (table 2). In the remaining populations,
most Tajima’s, Fu and Li’s, and Fay and Wu’s tests gave
significant negative values (table 7). When these analyses
were extended to NAT1 flanking regions, the same tests
lost significance in Bakola Pygmies, whereas they turned
out to be even more significant in French, Gujarati, and
Thai because of an excess of singletons when mutations
are not orientated for their ancestral state (TD and F*)
or because of an excess of highly frequent derived var-
iants when their ancestral state is considered (H). These
results are mainly due to the presence of the low-fre-
quency and highly divergent NAT1*11A haplotype in
the three Eurasian populations (fig. 2). As for the NAT2
coding region, both Tajima’s D and Fu and Li’s F* in
the Ashkenazi, Sardinians, and French and Fu and Li’s
F* in the Saami were significantly positive (table 7).
However, all tests were not significant anymore when
both flanking and exonic NAT2 variation was consid-
ered. As for NATP, although it was found to be in LD
with NAT2, all tests yielded nonsignificant values.
To test significant differences in diversity levels among
the three NAT loci, we performed the HKA test. The
comparison between NAT1 and NATP was significant
only among western and eastern Eurasians (Pp .046
and .043, respectively), resulting from an excess of poly-
morphisms in NAT1, compared with fixed mutations.
Again, these results are the consequence of the binary
haplotype pattern observed at this locus (fig. 2). By con-
trast, the HKA tests comparing NAT1 versus NAT2 and
NAT2 versus NATP yielded nonsignificant results. At
the protein level, we compared the number of synony-
mous and nonsynonymous mutations in the two ho-
mologous genes. NAT1 exhibited a deficit in nonsynon-
ymous mutations (KA/KS p 0.242). By contrast, NAT2
presented a KA/KS value closer to 1 (KA/KS p 0.802).
LRH Test for Recent Selection
We next performed the LRH test, which is designed
to identify mutations/haplotypes under recent positive
selection by comparing the frequency of a given allele
with the breakdown of LD around it (Sabeti et al. 2002).
Our results for both NAT1 and NAT2 are reported sep-
arately for African and Eurasian populations (fig. 4A
and 4B). P values were estimated for all core haplotypes
in all populations against both simulations and the em-
pirical distributions of the HapMap in Yoruban and Eu-
ropean-descent populations. A single haplotype of
NAT2 (NAT2*5B) appeared to deviate from neutrality
in western and central Eurasian populations: P psim
( ) in Ashkenazi Jews, .0062 (.0085).0001 P p .0006emp
in Saami, .0363 (.0063) in Turkmen, .0124 (.0607) in
Moroccans, and .0464 (.1836) in Swedish, with the same
haplotype in Sardinians being close to significance
(.0576 [.2178]). Interestingly, the NAT2*5B haplotype,
which exhibited the highest frequencies (150%) in west-
ern Eurasians (table 6), bears the nonsynonymous mu-
tation 341TrC (I114T), which has been shown to lead
to a slow-acetylation status (Zang et al. 2004). In ad-
dition, a single NAT1 haplotype (NAT1*4) appeared to
deviate from the simulated distribution in the same pop-
ulations that showed signals of positive selection for
NAT2*5B: ( ) in AshkenaziP p .0008 P p .0319sim emp
Jews, .0115 (.1346) in Saami, .0445 (.2498) in Turkmen,
.0293 (.2694) in Moroccans, and .0090 (.1987) in Swed-
ish. In contrast to NAT2*5B, the protein encoded by
the NAT1*4 haplotype does not differ in enzyme activity
with those encoded by the other NAT1 haplotypes ob-
served in this study (e.g., NAT1*10, NAT1*3, and
NAT1*11) (Hughes et al. 1998; de Leon et al. 2000).
Growth Rate and Age of the NAT2 341TrC Mutation
The LD breakdown at the surrounding sites of a mu-
tation is very informative for inferring allelic age esti-
mates, through consideration of the recombination rate
as a “genetic clock” (Labuda et al. 1997). The significant
signal of selection detected for the NAT2 341TrC mu-
tation, together with the functional consequences asso-
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Table 6
Allelic Composition and Frequency of NAT2
Haplotypes in Our Genotyping Panel
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Figure 2 NAT1 gene tree. Time is scaled in millions of years.
Mutations are named for their physical positions along the NAT1
locus. Lineage absolute frequencies in Africa and western and eastern
Eurasia are reported. Nonsynonymous mutations are highlighted in
gray.
ciated with this variant (i.e., reduced acetylation activ-
ity), prompted us to estimate the age of this mutation
by use of both maximum-likelihood and coalescent-
based methods, both of which gave similar results. To
provide a comparison, we performed the same analyses
for the 590GrA mutation, which is located 250 bp from
341TrC and is never observed on the same haplotype.
Our results indicated that these two mutations started
to increase in frequency at similar times and with com-
parable growth rates in all populations (table 8). The
only exception to this pattern was the 341TrC mutation
in western/central Eurasians. Our estimations showed
that this mutation started to increase in frequency 6,315
years ago (95% CI 5,797–7,005 years) at a growth rate
(0.062) twice as big as the values observed for the same
mutation in eastern Eurasians (0.031) and for 590GrA
in the entire Eurasian sample. Indeed, the growth rate
of 341TrC in western/central Eurasians was signifi-
cantly different from all the others, since their 95% CIs
did not overlap (table 8).
Acetylation Phenotype Inference
In view of the 95% NAT2 genotype-phenotype con-
cordance (Cascorbi et al. 1995), we inferred the distri-
bution of fast/slow–acetylation phenotypes across pop-
ulations from our NAT2 genotyping panel and com-
pared it with the phenotyping results of 23 healthy pop-
ulations worldwide, reviewed for this occasion (fig. 5).
To make both data sets comparable, we considered fast/
slow heterozygotes to be fast acetylators because, even
if they present a mean intermediate activity significantly
different from that of fast homozygotes, they are mostly
observed in the “fast acetylator activity peak” (Cascorbi
et al. 1995). Phenotype frequencies showed strong var-
iation among ethnic groups (fig. 5). The slow-acetylator
phenotype is present at the lowest frequencies in eastern
Asian and Native American populations as well as in
the Pygmy groups studied here for the first time, whereas
it exhibits the highest frequencies in Middle Eastern,
European, central/south Eurasian, and African popula-
tions. The highest frequencies worldwide of the slow-
acetylator phenotype are observed in the Ashkenazi pop-
ulation, in which it reaches 80%.
Discussion
The direct interaction of NAT1 and NAT2 gene products
with the human chemical environment makes them po-
tential targets of natural selection, provided that the ex-
posure to xenobiotics has significantly influenced pop-
ulation fitness over time. Our population-based genetic
study revealed distinctive patterns of variability for the
two NAT genes, reflecting two very different evolution-
ary histories.
Reduced Variation and Deep-Rooting Genealogy in
the NAT1 Gene
The NAT1 coding region is characterized by a reduced
genetic diversity ( ), with four populationspp 0.021%
of eight showing no variation at all (table 2). In addition,
the nearby 3′ UTR (TAA)n microsatellite of NAT1, which
was also typed in the genotyping panel, presented low
levels of heterozygosity ( ), with the alleleHzp 0.073
(TAA)8 accounting for 96.3% of the overall diversity
(table 5). This deficit in heterozygosity was significant
under both the stepwise mutation model and the two-
phased mutation model ( ). Also, in strong con-P ! .05
trast to NAT2, the functional mutations identified in
NAT1 are present at very low frequencies (Upton et al.
2001). These observations, together with the KA/KS value
of 0.242, are compatible with the action of purifying
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Figure 3 Proportion of SNP pairs in significant LD against physical distance in the NATs 200-kb region. In each population, genotyped
SNPs were selected to have a MAF 110%. The Fisher’s exact test was used to assess LD significance, followed by Bonferroni corrections. SNP
pairs were grouped into 20-kb bins.
selection in shaping NAT1 diversity, in agreement with
a previous study stating that the majority of human
genes may be under weak negative selection (Bustamante
et al. 2005). In this view, and considering that NAT1 is
expressed in many tissues early in development and may
play an additional role in the metabolism of folate (Sim
et al. 2000), our genetic results suggest that its involve-
ment in endogenous metabolic pathways might be more
important than previously thought.
Purifying selection may not be the only evolutionary
force that has influenced NAT1 diversity. Indeed, one
of the most salient observations of this study is the highly
divergent tree topology and high TMRCA (2.01  0.29
MYA) of this locus (fig. 2). This binary pattern is trans-
lated into significant departures from neutrality in pop-
ulations presenting the divergent haplotype NAT1*11A
(see table 7 and results of the HKA test). The probabil-
ity of finding such a high TMRCA under a Wright-Fisher
model was found to be low ( ). Different hy-Pp .029
potheses can be proposed to explain such long basal
branches in the NAT1 gene tree. First, long-term
balancing selection can result in divergent haplotype
clusters, by maintaining two or more alleles over time,
provided that they result in functional differences. Nev-
ertheless, our data do not support this hypothesis, since
the two nonsynonymous mutations separating the two
clusters (fig. 2) have been shown to have no significant
effects on the in vivo protein activity in human cells
(Hein 2002) or on the stability and activity of the re-
combinant protein in yeast (Hughes et al. 1998). Any
kind of selection due to a hitchhiking effect with neigh-
bor genes is equally unlikely, because the two closest
genes (ASAH1 located 5′ and NAT2 located 3′) behave
as independent haplotype blocks (this study and the
HapMap database). Furthermore, our sequence data
from the NAT1 coding region are consistent with the
action of purifying selection rather than balancing se-
lection, with the first selective regime having a minor
influence on tree topologies (Williamson and Orive
2002). Second, gene conversion could also lead to such
divergent haplotype patterns by the replacement of a
segment of NAT1 with a tract from its nearby paralogs
(NAT2 and/or NATP). This alternative is unlikely, how-
ever, since the 17 SNPs separating the two divergent
NAT1 lineages are not physically clustered (fig. 2) as one
would expect after gene conversion between duplicated
loci (Innan 2003). Thus, if gene conversion formed the
basis of such a haplotype pattern, multiple conversion
events must be invoked, with some tracts of lengths !5
bp. Yet, the conversion-tract lengths have been estimated
to range from 55 bp to 290 bp, through sperm-typing
analyses (Jeffreys and May 2004).
In this view, an alternative and most likely scenario
to explain our data is a demographic event such as an-
cient population structure. A number of studies have
recently reported gene genealogies that present not only
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Table 7
Sequenced-Based Neutrality Tests in NAT1, NAT2, and NATP
POPULATION
NAT1 CODING REGIONa
(870 bp)
NAT1 CODING AND
FLANKING REGIONS
(2,605 bp)
NAT2 CODING REGION
(870 bp)
NAT2 CODING AND
FLANKING REGIONS
(2,820 bp)
NATP PSEUDOGENE
(2,145 bp)
TD F* H TD F* H TD F* H TD F* H TD F* H
Bakola 1.513b 2.189b .190 .323 .298 .579 .007 .456 .653 .090 .852 1.726 .572 .228 .947
Bantu NA NA NA .563 .828 .632 .303 .193 .179 .091 .282 1.273 1.287 1.205 .011
Ashkenazi NA NA NA .044 .131 1.674 2.516c 1.797c .505 .374 .080 1.557 .545 1.255 .284
Sardinian NA NA NA .723 .295 .364 1.677b 1.548b .091 .164 .523 1.090 .295 .000 .576
French 1.723b 2.535b 3.505b 1.799b 2.925b 17.947c 2.048b 1.646b 1.021 .176 .014 1.789 .026 .119 1.011
Saami NA NA NA 1.443 1.383 .305 1.365 1.480b 1.358 1.017 1.281 3.136 .290 .135 .926
Gujarati 1.723b 2.535b 3.505b 1.974b 3.143c 18.600c 1.355 .895 1.242 1.135 .653 2.673 .393 .582 .326
Thai 1.384 .410 3.106b .904 .560 15.016c .818 1.281 .767 .441 .828 2.386 .809 .206 .344
a NA p not applicable (no variation observed).
b ..01 ! P ! .05
c .P ! .01
unexpectedly old coalescent times (∼2 MYA) but also
long basal branches (Harris and Hey 1999; Webster et
al. 2003; Barreiro et al. 2005; Garrigan et al. 2005;
Hayakawa et al. 2005). Our observations at NAT1, to-
gether with these studies, further support the view that
some diversity in the genome of modern humans may
have persisted from a structured ancestral population
(Harding and McVean 2004). In addition, NAT1*11A
appears to be absent in sub-Saharan Africa, since it was
not detected in either our genotyping panel of 144 sub-
Saharan Africans from distinct geographic locations or
600 African American individuals reported elsewhere
(Upton et al. 2001). Therefore, the observation that the
NAT1 gene tree is rooted in Eurasia questions the geo-
graphic location of such a structured ancestral popula-
tion (Takahata et al. 2001). The origins of NAT1*11A
could thus be placed either in sub-Saharan Africa, from
where it must have subsequently disappeared, or in Eur-
asia. Should the latter be the case, the NAT1 gene tree
is at odds with the commonly accepted replacement hy-
pothesis (Lewin 1987) and is more parsimoniously ex-
plained by the occurrence of partial hybridization be-
tween modern humans expanding from Africa and pre-
existing hominids in Eurasia, as recently sustained by
the RRM2P4 locus (Garrigan et al. 2005). However,
such inferences require further support from the analyses
of multiple independent loci in increased numbers of
samples and human populations.
The NAT2 Gene: An Advantage to Be a Slow
Acetylator?
The significantly positive values observed for most se-
quence-based neutrality tests of NAT2 in western Eu-
rasians (table 7) suggest the action of natural selection.
Likewise, population size reductions—such as that prob-
ably experienced by non-African populations during the
out-of-Africa exit (Marth et al. 2003) or, more recently,
by Ashkenazi Jews (Behar et al. 2004)—could have also
inflated TD and F* values (Przeworski et al. 2000).
However, these demographic events should have equally
influenced neutrality statistics for other non-African
populations (i.e., eastern Eurasians), which is not the
case. These observations argue thus in favor of the action
of natural selection. Conversely, interspecific tests (i.e.,
KA/KS and MK tests) do not rule out the neutral evo-
lution of NAT2 diversity, which does not show any clear
excess or lack of nonsynonymous mutations. In view of
these apparently contradictory results, it is plausible that
the frequencies, rather than the number of these muta-
tions, have been influenced by selection, suggesting more
subtle and recent fluctuations in the selective pressures
operating on NAT2.
Such changes can be detected by the LRH test, which
aims to identify haplotypes under recent positive selec-
tion. Moreover, this approach should be robust to the
confounding effects of demography, since it corrects the
extended haplotype homozygosity (EHH) of a given core
haplotype by the EHH of all other haplotypes at the
same core region (Sabeti et al. 2002). Overall, the LRH
tests were more significant when NAT1 and NAT2 core
haplotypes were compared with the simulated than with
the empirical distribution. Manifestly, the empirical dis-
tribution also includes genes under selection that bias
REHH toward higher values, and it allows the detection
of selected haplotypes in a conservative way. Indepen-
dently of which background distribution was used (e.g.,
simulated or empirical), the same NAT2 haplotype,
NAT2*5B, was detected to depart from neutrality in
western and central Eurasians (fig. 4B). These popula-
tions also showed significant P values for a single NAT1
haplotype, NAT1*4. It is worth mentioning that ∼80%
of NAT2*5B haplotypes are associated with NAT1*4
in western/central Eurasians (vs. 43% and 60% in sub-
Saharan Africans and eastern Eurasians, respectively).
Figure 4 REHH plotted against core haplotype frequencies. Circles represent NAT1 and NAT2 core haplotypes. The 95th and 99th
percentiles were calculated from both simulated data (gray lines) and an empirical distribution obtained from the screening of the entire
chromosome 8 (black lines). Circles above the 95th percentile of simulated and/or empirical distributions are blackened. A, NAT1 and NAT2
sub-Saharan African core haplotypes are plotted against both simulated data and the empirical distribution of ∼40,000 Yoruban core haplotypes
from the HapMap. B, NAT1 and NAT2 core haplotypes in western/central and eastern Eurasian populations are plotted against both the
simulated data and the empirical distribution of ∼40,000 European-descent core haplotypes from the HapMap. Numbers affiliated with significant
core haplotypes refer to: (1) Moroccan NAT2*5B, (2) Swedish NAT2*5B, (3) Turkmen NAT1*4, (4) Moroccan NAT1*4, (5) Saami NAT1*4,
and (6) Swedish NAT1*4.
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Table 8
Estimated Growth Rate and Age of the Mutations 341TrC and 590GrA (95% CI) of the NAT2
Gene
Mutation
and Parameter Sub-Saharan Africans
Western/
Central Eurasians Eastern Eurasians
341TrC:
p .270 .477 .181
r .019 (.016–.024) .062 (.055–.075) .031 (.028–.037)
g 15,652 (13,797–18,435) 6,315 (5,797–7,005) 12,627 (11,427–14,685)
590GrA:
p .185 .262 .362
r .023 (.020–.030) .031 (.028–.037) .034 (.031–.041)
g 12,497 (10,932–14,958) 12,762 (11,657–14,385) 11,987 (10,940–13,643)
NOTE.—p p relative frequency of the mutation; r p growth rate; g p age of the mutation in
years.
Thus, the signals detected in both NAT1 and NAT2 may
be the result of a single event of selection targeting a
long-range haplotype composed of both NAT1*4 and
NAT2*5B. Several lines of evidence, however, strongly
support that the NAT1 haplotype does not harbor the
functional cause of such a selective event: P values are
globally less significant for NAT1*4 than for NAT2*5B,
and, most importantly, all the NAT1 haplotypes ob-
served in this study encode proteins with identical en-
zymatic activity (Hughes et al. 1998; de Leon et al.
2000). In sharp contrast, NAT2*5B bears the 341TrC
mutation that is well known to encode an altered slow-
acetylator protein (Zang et al. 2004).
Further support for the action of selection on the slow-
encoding 341TrC NAT2 mutation comes from its
growth-rate estimate, which showed that this mutation
has increased in frequency twice as quickly as expected
( ) (table 8) only among western and centralrp 0.062
Eurasians. Previous estimations (Slatkin and Bertorelle
2001), together with our own, indicate that Eurasian
populations have grown at a rate of ∼0.030. Because
population growth and selection have additive effects on
the growth rate of a mutation (Slatkin and Rannala
1997), these observations suggest that the 341C allele
has been driven by selection with a selective coefficient
of ∼ . Using a more accurate ap-0.062 0.030p 0.032
proach (Wright 1969), we estimated the 95% CI of this
selective coefficient as 0.0124–0.0913. These figures re-
inforce the idea of a selective advantage of the 341C
allele, even if weaker than other examples of recent but
strong positive selection, such as lactase persistence (s
∼0.09–0.19) (Bersaglieri et al. 2004) or the G6PD A
alleles ( ) (Saunders et al. 2005).s 1 0.1
Altogether, both the LRH test and the growth rate of
341TrC argue in favor of positive selection acting on
this slow-encoding mutation, which would imply a gen-
eral selective advantage for the slow-acetylator pheno-
type. However, three other NAT2 variants (191GrA,
590GrA, and 857GrA) also encode slow proteins but
do not show any significant departure from neutrality.
Actually, the 341TrC mutation involves the greatest re-
duction in NAT2 enzymatic activity (Hein et al. 2000).
In this context, it is very plausible that all NAT2 slow-
acetylating variants have been subject to weak selective
pressures, the signal of selection being detectable only
in the mutation 341TrC causing the “slowest-acetyla-
tion” phenotype. Thus, the predicted increase in fre-
quency of all slow mutations, in response to directional
selection, would explain the observed excess of inter-
mediate-frequency alleles in western Eurasian popula-
tions, as depicted by the significant positive values of
TD (table 7).
The footprints of natural selection identified in west-
ern/central Eurasians raise the question of which event(s)
may have provoked fluctuations in the spectrum of xe-
nobiotics inactivated/activated by NAT2 (e.g., NAT2 ac-
tivates heterocyclic carcinogens found in well-cooked
meat [Hein et al. 2000; Hein 2002]) in these populations.
In this context, given the geographic distribution of the
slow-acetylator phenotype and the estimated expansion
time of the slowest-encoding 341TrC mutation (5,797–
7,005 years ago in western/central Eurasians), it is
tempting to hypothesize that the emergence of agricul-
ture in western Eurasia could be at the basis of such
environmental changes. Indeed, there is accumulating
evidence that this major transition resulted in a profound
modification of human diets and lifestyles (Cordain et
al. 2005) and, consequently, in the exposure of humans
to chemical environments (Ferguson 2002). Moreover,
the highest frequencies of slow acetylators are observed
in the Middle East (fig. 5), one of the first regions where
agriculture originated ∼10,000 years ago, and these fre-
quencies decrease toward western Europe, North Africa,
and India, three regions where agriculture was subse-
quently diffused from the Fertile Crescent (Harris 1996).
However, the hypothesis that the transition to agricul-
ture influenced both the human exposure to xenobiotic
environments and, consequently, the selective pressures
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Figure 5 Worldwide distribution of NAT2 acetylation phenotypes in healthy individuals. Each pie represents the population proportion
of fast and slow acetylators. Populations numbered from 1 to 13 were analyzed in this study: (1) Bakola Pygmies, (2) Baka Pygmies, (3) Ateke
Bantus, (4) Somali, (5) Morrocans, (6) Ashkenazi Jews, (7) Sardinians, (8) Swedes, (9) Saami, (10) Turkmen, (11) Gujarati, (12) Thai, and (13)
Chinese. Numbers 14 to 36 refer to a reviewed population: (14) Yorubas (Jeyakumar and French 1981), (15) Zimbabweans (Nhachi 1988),
(16) South Africans (Hodgkin et al. 1979), (17) Libyans (Karim et al. 1981), (18) Saudi Arabians (El-Yazigi et al. 1992), (19) Emiratis (Woolhouse
et al. 1997), (20) Iranians (Sardas et al. 1993), (21) Jordanians (Irshaid et al. 1992), (22) Turkmen (Bozkurt et al. 1990), (23) Greeks (Asprodini
et al. 1998), (24) Germans (Cascorbi et al. 1995), (25) Russians (Lil’in et al. 1984), (26) Pakistanis (Saleem et al. 1989), (27) Bangladeshi (Zaid
et al. 2004), (28) Thai (Kukongviriyapan et al. 1984), (29) Malaysians (Ong et al. 1990), (30) Chinese (Zhao et al. 2000), (31) Koreans (Lee
et al. 2002), (32) Japanese (Hashiguchi and Ebihara 1992), (33) Papua New Guineans (Hombhanje 1990), (34) Australian Aborigines (Ilett et
al. 1993), (35) Eskimos (Eidus et al. 1974), and (36) Amerindians (Jorge-Nebert et al. 2002).
at NAT2 remains tentative and requires a better char-
acterization of the naturally occurring substrates of the
NAT2 enzyme.
Conclusion
The diversity patterns observed at the NATs region
clearly illustrate our current vision of the human genome
as a “mosaic of discrete segments,” each with its own
individual evolutionary history (Pa¨a¨bo 2003). Whereas
NAT1 could belong to a small proportion of nuclear loci
that kept traces of an ancient population structure, the
NAT2 gene gives some insights into the evolutionary
processes that could make some present-day detrimental
mutations frequent. The theory of the “thrifty genotype”
proposes that common diseases, such as obesity and di-
abetes, are the result of a past advantage to efficiently
metabolize rare food sources that are no longer restricted
(Neel 1962). By analogy, the slow NAT2 acetylator hap-
lotype (NAT2*5B), which is found at high frequencies
worldwide and which we propose conferred some se-
lective advantage, at least in western/central Eurasian
populations, exhibits today the strongest association
with susceptibility to bladder cancer and adverse drug
reactions (Hein et al. 2000; Hein 2002). This “evolu-
tionary conflict” could be widespread among genes in-
volved in carcinogen metabolism, since two major events
in human history—the Neolithic transition from for-
aging to agriculture and the more recent Industrial Rev-
olution—may have dramatically changed our exposure
to the damaging effects of environmental carcinogens.
Consequently, dissecting the evolutionary processes that
have shaped patterns of diversity of the genes involved
in drug metabolism may represent a major analytical
tool not only to identify those having played a crucial
role in the past adaptation of Homo sapiens but also
to better understand our present-day susceptibility to
disease.
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